Evidence map›Paper›PMID 35583360›Full record

ArticleMicrobiology spectrum2022

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.

María M Lorenzo, Aitor Nogales, Kevin Chiem, Rafael Blasco, Luis Martínez-Sobrido

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

María M Lorenzo *Departamento de Biotecnología, Centro Nacional INIA, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Aitor Nogales *Department of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.ORCID 0000-0002-2424-7900
Kevin ChiemDepartment of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.
Rafael BlascoDepartamento de Biotecnología, Centro Nacional INIA, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Luis Martínez-SobridoDepartment of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.ORCID 0000-0001-7084-0804
Consejo Superior de Investigaciones Científicas · ESTexas Biomedical Research Institute · USInstitute of Agrifood Research and Technology · ES

Funding

Attenuation Of Lassa Virus Via Codon Deoptimization​R21AI135284 · NIAID · UNIVERSITY OF ROCHESTER · PI MARTINEZ-SOBRIDO, LUIS · 2018 to 2019
$522k
NIAID NIH HHS R21 AI135284
6 · The paper itself

Abstract

Poxviruses have large DNA genomes, and they are able to infect multiple vertebrate and invertebrate animals, including humans. Despite the eradication of smallpox, poxvirus infections still remain a significant public health concern. Vaccinia virus (VV) is the prototypic member in the

Indexed as

PoxviridaeSmallpoxViral VaccinesVirusesAnimalsCodonVaccine DevelopmentVaccines, AttenuatedVaccinia virusViral Replicase Complex ProteinsCodonVaccines, AttenuatedViral Replicase Complex ProteinsViral VaccinesA24R genecodon biascodon deoptimizationGFPlive-attenuated vaccinesvaccinia virus

Identifiers

PMID35583360
PMCPMC9241885
OpenAlexW4280624083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.